An in-depth review of randomized trials on screening for breast, colorectal, cervical, prostate and lung cancers shows that the benefits of mammographic screening are likely to have been overestimated.
from Today's Healthcare News -- ScienceDaily http://ift.tt/1Rl3UAN
No comments:
Post a Comment